Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 233
Filter
1.
Arch. argent. pediatr ; 121(6): e202310035, dic. 2023. tab, graf
Article in English, Spanish | BINACIS, LILACS | ID: biblio-1517944

ABSTRACT

Los niños con lesiones selares y/o supraselares pueden presentar diabetes insípida central con posterior secreción inadecuada de hormona antidiurética. Nosotros observamos, en algunos casos, aumento de la incidencia de poliuria, natriuresis e hiponatremia, tríada diagnóstica del síndrome cerebral perdedor de sal. Aquí comunicamos la evolución de 7 pacientes con antecedentes de daño agudo del sistema nervioso central y diabetes insípida central seguida por síndrome cerebral perdedor de sal. Como tratamiento aportamos secuencialmente fluidos salinos parenterales, cloruro de sodio oral, desmopresina, mineralocorticoides e incluso tiazidas. Ante la persistencia de poliuria con hiponatremia, agregamos ibuprofeno. Como resultado de este esquema terapéutico secuencial, este grupo redujo significativamente los valores de diuresis diaria de 10 ml/kg/h a 2 ml/kg/h en un tiempo promedio de 5 días, normalizando también las natremias (de 161 mEq/L a 143 mEq/L) en un tiempo promedio de 9 días. En ningún caso observamos efectos adversos asociados al tratamiento.


Children with sellar and/or suprasellar lesions may develop central diabetes insipidus with subsequent inappropriate antidiuretic hormone secretion. An increased incidence of polyuria, natriuresis, and hyponatremia has been reported in some cases, which make up the diagnostic triad of cerebral salt wasting syndrome. Here we report the clinical course of 7 patients with a history of acute central nervous system injury and central diabetes insipidus followed by cerebral salt wasting syndrome. Treatment included the sequential use of parenteral saline solution, oral sodium chloride, desmopressin, mineralocorticoids, and even thiazides. Due to persistent polyuria and hyponatremia, ibuprofen was added. As a result of this sequential therapeutic regimen, daily urine output reduced significantly from 10 mL/ kg/h to 2 mL/kg/h over an average period of 5 days, together with a normalization of natremia (from 161 mEq/L to 143 mEq/L) over an average period of 9 days. No treatment-related adverse effects were observed in any case.


Subject(s)
Humans , Child, Preschool , Child , Adolescent , Diabetes Insipidus, Neurogenic , Hyponatremia/etiology , Hyponatremia/drug therapy , Polyuria/complications , Polyuria/etiology , Research , Ibuprofen/therapeutic use
2.
Rev. méd. Chile ; 151(4): 518-523, abr. 2023. tab, ilus
Article in Spanish | LILACS | ID: biblio-1560193

ABSTRACT

The relief of the impediment to urinary flow is the treatment of acute kidney failure due to urinary tract obstruction. However, there is a risk of inducing massive polyuria, which can be self-limited or produce severe contraction of the intravascular volume with pre-renal acute kidney failure and alterations in the internal environment. Polyuria, urine output > 3 L/d or > 200 mL/min for more than 2 hours, can have multiple causes, and can be classified as osmotic, aqueous or mixed. Post-obstructive polyuria obeys different pathogenic mechanisms, which overlap and vary during a patient's evolution. Initially, there is a decrease in vasoconstrictor factors and an increase in renal blood flow, which, added to the excess of urea accumulated, will cause intense osmotic diuresis (osmotic polyuria due to urea). Added to these factors are the positive sodium and water balance during acute renal failure, plus the contributions of crystalloid solutions to replace diuresis (ionic osmotic polyuria). Finally, there may be tubular dysfunction and decreased solutes in the renal medullary interstitium, adding resistance to the action of vasopressin. The latter causes a loss of free water (mixed polyuria). We present the case of a patient with post-obstructive polyuria where, by analyzing the clinical symptoms and laboratory alterations, it was possible to interpret the mechanisms of polyuria and administer appropriate treatment for the pathogenic mechanism.


Subject(s)
Humans , Male , Middle Aged , Polyuria/etiology , Polyuria/physiopathology , Ureteral Obstruction/complications , Ureteral Obstruction/physiopathology , Urethral Obstruction/physiopathology
3.
Arq. ciências saúde UNIPAR ; 26(3): 458-469, set-dez. 2022.
Article in English | LILACS | ID: biblio-1399130

ABSTRACT

Objectives: This study aimed to make a bibliographic update on the already published data on bumetanide, addressing the main information on its use in Autism Spectrum Disorder (ASD). Methods: This was an integrative narrative review in which the following databases were used: Web of Science, MEDLINE, ScienceDirect, and Scielo. The descriptors used were: Autism Spectrum Disorder, Autistic Disorder and Bumetanide. It was considered only articles published in English and French. Original articles, randomized clinical trials, case reports, and review articles were included. Results: The results show that the use of bumetanide alters regions of the brain linked to the positive development of language, improvement of visual contact, improvement in social interactions, among others. Studies are also concerned about the safety and efficacy of bumetanide in ASD since several adverse effects have been reported. The most frequent were hypokalemia, polyuria, and loss of appetite. Conclusion: Bumetanide has proven as effective in improving some important symptoms in ASD, especially linked to language and social interaction, however, studies with larger groups of patients and with longer treatment and observation time are needed to confirm the efficacy and clarify the safety profile in use for people with ASD.


Objetivo: O objetivo deste trabalho foi fazer uma atualização bibliográfica sobre os dados já publicados da bumetanida, abordando as principais informações sobre seu uso no Transtorno do Espectro Autista (TEA). Metodologia: Foi realizada uma revisão do tipo narrativa integrativa, da qual foram utilizadas as bases de dados: Web of Science, MEDLINE, ScienceDirect e Scielo, com a utilização dos seguintes descritores: Autism Spectrum Disorder, Autistic Disorder e Bumetanide. Foram considerados apenas artigos publicados nas línguas inglesa e francesa. Foram incluídos artigos originais, ensaios clínicos randomizados e relatos de caso. Foram excluídos artigos de revisão. Resultados: Os resultados mostram que o uso da bumetanida altera regiões do cérebro ligadas ao desenvolvimento positivo da linguagem, melhora do contato visual, melhora nas interações sociais, entre outros. Os estudos também se preocupam em relacionar a segurança e a eficácia da bumetanida no TEA, do qual foram relatados diversos efeitos adversos, sendo os mais frequentes a hipocalemia, a poliúria e a perda de apetite. Conclusão: A bumetanida mostrou ser eficaz na melhoria de alguns importantes sintomas no TEA, especialmente ligados à linguagem e interação social, entretanto, estudos com grupos maiores de pacientes e com maior tempo de tratamento e observação são necessários para confirmar a eficácia e esclarecer o perfil de segurança no uso para pessoas com TEA.


: Este estudio tuvo como objetivo realizar una actualización bibliográfica sobre los datos ya publicados sobre la bumetanida, abordando la principal información sobre su uso en el Trastorno del Espectro Autista (TEA). Métodos: Se trata de una revisión narrativa integradora en la que se utilizaron las siguientes bases de datos: Web of Science, MEDLINE, ScienceDirect y Scielo. Los descriptores utilizados fueron: Trastorno del Espectro Autista, Trastorno Autista y Bumetanida. Se consideraron sólo los artículos publicados en inglés y francés. Se incluyeron artículos originales, ensayos clínicos aleatorios, informes de casos y artículos de revisión. Resultados: Los resultados muestran que el uso de la bumetanida altera regiones del cerebro relacionadas con el desarrollo positivo del lenguaje, la mejora del contacto visual, la mejora de las interacciones sociales, entre otros. Los estudios también se preocupan por la seguridad y eficacia de la bumetanida en el TEA, ya que se han reportado varios efectos adversos. Los más frecuentes fueron la hipocalemia, la poliuria y la pérdida de apetito. Conclusiones: La bumetanida ha demostrado ser eficaz en la mejora de algunos síntomas importantes en el TEA, especialmente vinculados al lenguaje y la interacción social, sin embargo, se necesitan estudios con grupos más grandes de pacientes y con mayor tiempo de tratamiento y observación para confirmar la eficacia y aclarar el perfil de seguridad en el uso para personas con TEA.


Subject(s)
Autistic Disorder/drug therapy , Bumetanide/adverse effects , Bumetanide/pharmacology , Autism Spectrum Disorder/drug therapy , Appetite Depressants/antagonists & inhibitors , Polyuria , Drug-Related Side Effects and Adverse Reactions , Social Interaction/drug effects , Language Development
4.
Article in Portuguese | LILACS | ID: biblio-1353115

ABSTRACT

A intoxicação por vitamina D era pouco frequente no Brasil até seu crescente uso na última década. Neste artigo relatamos um caso de intoxicação por vitamina D em que houve a prescrição intencional de dose muito superior ao recomendado pela literatura, com a finalidade de prevenir doenças via "modulação hormonal". A paciente em questão, idosa, previamente hígida, foi submetida a um tratamento não regulamentado e sem respaldo científico, que culminou em sintomas como náuseas e vômitos, além de perda de peso, inapetência, poliúria e astenia ao longo dos meses. Através da história e exames laboratoriais foi diagnosticada intoxicação por vitamina D e lesão renal aguda. Após o tratamento houve remissão completa dos sintomas. A "modulação hormonal" é uma prática condenada pelos Conselhos Federais de Medicina e Odontologia e pela Sociedade Brasileira de Endocrinologia e Metabologia. O ato de prescrever é de grande responsabilidade ética e técnica e deve ser embasado em evidências científicas, oferecendo o melhor tratamento possível aos pacientes, seja ele preventivo ou curativo, minimizando riscos e danos, respeitando as recomendações das autoridades competentes. (AU)


Vitamin D poisoning was not frequent in Brazil until its increasing use in the last decade. In this article, we report a case of intoxication by intentional prescription of vitamin D in a much higher dose than the literature recommends, in order to prevent diseases via "hormonal modulation". The case described in this report was an elderly woman, previously healthy patient that was submitted to an unregulated treatment without scientific support, leading to symptoms such as nausea and vomiting, in addition to weight loss, lack of appetite, polyuria and asthenia over the months. Through the history and laboratory testing, vitamin D intoxication and acute kidney injury were diagnosed. After treatment, there was a complete remission of the symptoms. "Hormonal modulation" is a practice condemned by the Federal Councils of Medicine and Dentistry and by the Brazilian Society of Endocrinology and Metabology. The act of prescribing is of great ethical and technical responsibility and it must be based on scientific evidence. Thus, the patient can receive the best possible treatment, for either preventive or curative nature, by respecting the recommendations of the competent authorities and, therefore, minimizing risks and damages to patients. (AU)


Subject(s)
Humans , Female , Aged , Polyuria , Asthenia , Vitamin D/toxicity , Weight Loss , Anorexia , Ethics, Professional , Acute Kidney Injury
5.
Annals of Pediatric Endocrinology & Metabolism ; : 68-70, 2019.
Article in English | WPRIM | ID: wpr-762586

ABSTRACT

Congenital rubella infection is a transplacental infection that can cause intrauterine growth retardation, cataracts, patent ductus arteriosus, hearing loss, microcephaly, thrombocytopenia, and severe fetal injury. It has been shown that type 1 diabetes mellitus develops in 12%–20% of patients with congenital rubella infection, and disorders in the oral glucose tolerance test is observed in 40% of patients. No biochemical or serological markers exist which could indicate that type 1 diabetes was caused by a congenital rubella infection. We report a 13-year-old male patient who was admitted to our hospital with complaints of new-onset polyuria, polydipsia, urination, and weight loss. In addition, he was found to have neurosensory hearing loss, patent ductus arteriosus, and microcephaly. Immunemediated type 1 diabetes mellitus was considered due to the fact that the autoantibodies of diabetes mellitus were positive.


Subject(s)
Adolescent , Humans , Male , Autoantibodies , Cataract , Diabetes Mellitus , Diabetes Mellitus, Type 1 , Ductus Arteriosus, Patent , Fetal Growth Retardation , Glucose Tolerance Test , Hearing Loss , Microcephaly , Polydipsia , Polyuria , Rubella , Thrombocytopenia , Urination , Weight Loss
6.
Natural Product Sciences ; : 261-267, 2019.
Article in English | WPRIM | ID: wpr-760562

ABSTRACT

The rhizomes of Dioscorea japonica Thunb. are widely consumed as food and also used to treat diabetes and polyuria in Korea. This study was undertaken to study the anti-atopic dermatitis effects of a 95% ethanolic extract (DJE) of D. japonica in an oxazolone-stimulated murine model of atopic dermatitis (AD). The therapeutic effects of DJE on AD-like skin lesions were assessed on both ears. DJE (1%) or dexamethasone (0.5%; the positive control) were applied to skin lesions for three weeks. Serum levels of IgE and IL-4 were assessed by ELISA (enzyme-linked immunosorbent assay). Histopathological examinations were performed by hematoxylin and eosin (H&E) and toluidine blue staining and revealed DJE significantly reduced dermal thickness and inflammatory cell infiltration when applied to oxazolone-treated ear skin. DJE-treated AD mice also showed lower serum levels of IgE and IL-4 than oxazolone-stimulated controls. Our findings demonstrate DJE might be a useful safe, topical agent for the treatment of atopic diseases.


Subject(s)
Animals , Mice , Dermatitis , Dermatitis, Atopic , Dexamethasone , Dioscorea , Ear , Enzyme-Linked Immunosorbent Assay , Eosine Yellowish-(YS) , Ethanol , Hematoxylin , Immunoglobulin E , Interleukin-4 , Korea , Oxazolone , Polyuria , Rhizome , Skin , Therapeutic Uses , Tolonium Chloride
7.
International Neurourology Journal ; : 91-99, 2019.
Article in English | WPRIM | ID: wpr-764116

ABSTRACT

This article reviewed the current knowledge on time-course manifestation of diabetic urethral dysfunction (DUD), and explored an early intervention target to prevent the contribution of DUD to the progression of diabetes-induced impairment of the lower urinary tract (LUT). In the literature search through PubMed, key words used included “diabetes mellitus,” “diabetic urethral dysfunction,” and “diabetic urethropathy.” Polyuria and hyperglycemia induced by diabetes mellitus (DM) can cause the time-dependent changes in functional and morphological manifestations of DUD. In the early stage, it promotes urethral dysfunction characterized by increased urethral pressure during micturition. However, the detrusor muscle of the bladder tries to compensate for inducing complete voiding by increasing the duration and amplitude of bladder contractions. As the disease progresses, it can induce an impairment of coordinated micturition due to dyssynergic activity of external urethra sphincter, leading to detrusor-sphincter dyssynergia. The impairment of relaxation mechanisms of urethral smooth muscles (USMs) may additionally be attributable to decreased responsiveness to nitric oxide, as well as increased USM responsiveness to α1-adrenergic receptor stimulation. In the late stage, diabetic neuropathy may play an important role in inducing LUT dysfunction, showing that the decompensation of the bladder and urethra, which can cause the decrease of voiding efficiency and the reduced thickness of the urothelium and the atrophy of striated muscle bundles, possibly leading to the vicious cycle of the LUT dysfunction. Further studies to increase our understandings of the functional and molecular mechanisms of DUD are warranted to explore potential targets for therapeutic intervention of DM-induced LUT dysfunction.


Subject(s)
Ataxia , Atrophy , Diabetes Mellitus , Diabetic Neuropathies , Early Intervention, Educational , Hyperglycemia , Lower Urinary Tract Symptoms , Muscle, Smooth , Muscle, Striated , Nitric Oxide , Polyuria , Relaxation , Urethra , Urinary Bladder , Urinary Tract , Urination , Urothelium
8.
Esc. Anna Nery Rev. Enferm ; 23(4): e20190084, 2019. tab, graf
Article in English | BDENF, LILACS | ID: biblio-1039808

ABSTRACT

Abstract Objective: Identify by means of a management tool causes of losses of possible and potential organs and tissues donation as opportunities of improvements in the organs and tissues donation system. Method: Descriptive and quantitative study developed in three hospitals in the south of the country, which used an instrument of the National Transplant Organization of Spain to trace opportunities of improvements in the scenario of the organs and tissues donation. Tha data collect was carried out in patients´medical records from July and October 2017. The data were analyzed through the descriptive statistics. Results: Of the 321 deaths occurred, 73% were heart arrested and 27% were brain death. In all hospitals the percentage of brain death was higher than 25%. The causes of losses involve hemodynamic alterations 78.3% and medical contraindications 21,7%, with respect to hemodynamic instability 33% related to the hypotension, polyuria 28% , sodium more than 155mEq/l 22% and temperature below 35.5ºC in 17%. Conclusion and Implications for practice: The main causes of loss involve the hemodynamic instability and the contraindication, with respect to opportunities of improvements it was possible to measure the causes of the non-validation of the potential organs donor. The management tool used in the study allows the healthcare team to develop strategies directed towards actual problems incurred at the stages of the donation and transplantation process.


Resumen Objetivo: Identificar por medio de una herramienta de gestión causas de pérdidas de posibles y potenciales donantes de órganos y tejidos como oportunidades de mejorías en el sistema de donación de órganos y tejidos. Método: Estudio cuantitativo, descriptivo, desarrollado en tres hospitales en el sul del País, el cual utilizó un instrumento de la Organización Nacional de Trasplantes de España para rastrear oportunidades de mejorias en el escenario de la donación de órganos y tejidos. La recolección de datos fue realizada en historial clínico de pacientes entre julio y octubre de 2017. Los datos fueron analizados por medio de la estadística descriptiva. Resultados: De las 321 muertes ocurridas, 73% eran de corazón parado y 27% de muertes encefálica. En todos los hospitales el porcentaje de muertes encefálica fue superior a 25%. Las causas de las pérdidas incluyen alteraciones hemodinámicas 78,3% y contraindicaciones de carácter médico 21,7%, cuando la instabilidad hemodinámica 33% relacionadas con la hipotensión, poliuria 28% , sodio superior a 155mEq/l 22% y temperatura inferior a 35,5ºC en 17%. Conclusión y Implicaciones para la práctica: Las principales causas de la pérdida incluyen la instabilidad hemodinánica y la contraindicación, en el que se refiere a las oportunidades de mejorías ha podido ser medido la real, las principales causas de la no validación del potencial donante de órganos. La herramienta de gestión utilizada en el estudio permite a el equipo de salud desarrollar estrategias dirigidas a problemas reales ocasionados en las etapas del proceso de donación y trasplante.


Resumo Objetivo: Identificar por meio de uma ferramenta de gestão causas de perdas de possíveis e potenciais doadores de órgãos e tecidos como oportunidades de melhorias no sistema de doação de órgãos e tecidos. Método: Estudo quantitativo, descritivo, desenvolvido em três hospitais no Sul do País, o qual utilizou um instrumento da Organização Nacional de Transplantes da Espanha para rastrear oportunidades de melhorias no cenário da doação de órgãos e tecidos. A coleta de dados foi realizada em prontuários de pacientes entre julho e outubro de 2017. Os dados foram analisados por meio da estatística descritiva. Resultados: Das 321 mortes ocorridas, 73% eram de coração parado e 27% de morte encefálica. Em todos os hospitais a porcentagem de morte encefálica foi superior a 25%. As causas das perdas envolvem alterações hemodinâmicas 78,3% e contraindicações médicas 21,7%, quanto a instabilidade hemodinâmica 33% relacionadas a hipotensão, poliúria 28% , sódio superior a 155mEq/l 22% e temperatura inferior a 35,5ºC em 17%. Conclusão e Implicações para a prática: As principais causas de perda envolvem a instabilidade hemodinânica e a contraindicação, no que se refere as oportunidades de melhorias foi possível mensurar as principais causas da não validação do potencial doador de órgãos. A ferramenta de gestão utilizada no estudo permite a equipe de saúde desenvolver estratégias direcionadas a problemas reais ocasionados nas etapas do processo de doação e transplante.


Subject(s)
Humans , Tissue Donors/statistics & numerical data , Tissue and Organ Procurement/organization & administration , Patient Care Team/organization & administration , Polyuria , Tissue and Organ Procurement/statistics & numerical data , Brain Death/diagnosis , Disease Notification/statistics & numerical data , Education, Continuing , Hemodynamics , Hypernatremia , Hypotension , Hypothermia
9.
Childhood Kidney Diseases ; : 67-70, 2018.
Article in English | WPRIM | ID: wpr-739196

ABSTRACT

Primary polydipsia (PP) is marked by an increase in thirst, and most often presents in patients with psychiatric illnesses. Although uncommon in children, we experienced cases of PP in a 15-month-old boy and a 5-year-old girl. Both were admitted to the hospital with symptoms of polydipsia and polyuria that appeared 1–3 months before admission. Brain magnetic resonance imaging in both patients was normal. A water restriction test was performed after hospitalization and showed normal results. The symptoms improved after the parents were instructed to implement water-intake restriction for 2 weeks. Our report provides useful information for the treatment of PP in children.


Subject(s)
Child , Child, Preschool , Female , Humans , Infant , Male , Brain , Diabetes Insipidus , Hospitalization , Magnetic Resonance Imaging , Parents , Polydipsia , Polydipsia, Psychogenic , Polyuria , Thirst , Water
10.
Brain Tumor Research and Treatment ; : 73-77, 2018.
Article in English | WPRIM | ID: wpr-717502

ABSTRACT

Germinoma is the most common type of intracranial germ cell tumors (GCTs). Pineal gland and suprasellar region are the most frequent sites of central nervous system (CNS) involvement. Intracranial masses caused by Langerhans cell histiocytosis (LCH) mimics features of CNS GCTs. LCH frequently involve spine and is the most common cause of vertebra plana in children. A 15-year-old boy presented with progressing symptoms of polydipsia, polyuria, general headache, nausea and severe back pain. Brain MRI showed brain tumor with simultaneous involvement of suprasellar region and pineal gland. An excisional biopsy of suprasellar mass was done. The pathologic assessment confirmed the diagnosis of germinoma. Patient's treatment continued accordingly. A spine MRI, done due to persistent backache, showed a vertebra plana. We reevaluated the primary diagnosis suspecting LCH. Germinoma of CNS was confirmed and a biopsy of vertebral lesion resulted in hemangioma. Thus we report a case of CNS germinoma with co-occurrence of vertebra plana. We emphasized the importance of histopathologic diagnosis of pineal/suprasellar masses and primary investigation of other CNS regions including spine for possible metastasis or comorbidities.


Subject(s)
Adolescent , Child , Humans , Male , Back Pain , Biopsy , Brain , Brain Neoplasms , Central Nervous System , Comorbidity , Diagnosis , Germinoma , Headache , Hemangioma , Histiocytosis, Langerhans-Cell , Magnetic Resonance Imaging , Nausea , Neoplasm Metastasis , Neoplasms, Germ Cell and Embryonal , Pineal Gland , Polydipsia , Polyuria , Spine
11.
Rev. chil. endocrinol. diabetes ; 10(3): 107-110, jul. 2017. ilus, tab
Article in Spanish | LILACS | ID: biblio-998995

ABSTRACT

Infundibuloneurohypophysitis is a rare condition, which is part of the group of hypophysitis, of relatively recent description (1993). The main clinical manifestation is diabetes insipidus, whose natural evolution is towards chronicity. The differential diagnosis with other thickening of the hypophysial stem is very important, where the clinic, imaging, laboratory and eventually biopsy are a main support for a correct diagnosis. We present a clinical case that shows the usual picture of infundibuloneurohypophysitis, and illustrates the imaging evolution in a female patient, with diabetes insipidus as the main clinical manifestation


Subject(s)
Humans , Female , Adult , Pituitary Diseases/complications , Pituitary Diseases/diagnosis , Diabetes Insipidus/etiology , Pituitary Diseases/diagnostic imaging , Polyuria/etiology , Polyuria/drug therapy , Deamino Arginine Vasopressin/therapeutic use , Diabetes Insipidus/drug therapy , Diuresis/drug effects , Antidiuretic Agents/therapeutic use , Polydipsia/etiology , Polydipsia/drug therapy
12.
Journal of Korean Diabetes ; : 125-133, 2017.
Article in Korean | WPRIM | ID: wpr-727038

ABSTRACT

The primary causes of uncontrolled diabetes are poor life-style, infection, ischemic heart disease and inappropriate usage of oral anti-diabetic agents and insulin. Supplementary causes are stroke, acute pancreatitis and endocrine diseases. Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant syndrome characterized by primary hyperparathyroidism, pituitary neoplasia, and foregut lineage neuroendocrine tumors, and is associated with increased glucose levels. We present a case of a 69-year-old woman who had polyuria, polydipsia, weight loss and hyperglycemia over 6 months. She had hypertrophy of the face, hand, and foot, and active bleeding and large folds were observed in the stomach and duodenum upon esophagogastroduodenoscopy. She also had high levels of IGF-1 and gastrin and got the failure of growth hormone suppression after an oral glucose load (75 g). These findings suggested a diagnosis of acromegaly and gastrinoma, which was clinically diagnosed along with MEN 1. The patient improved glycemic control and symptoms after being treated with somatostatin analogues and insulin therapy over a 5-month follow-up period. Here, we report a case of MEN 1 in type 2 diabetes mellitus with a poorly controlled blood glucose level. Clinicians should consider endocrine disease in patients with poor glycemic control in diabetes.


Subject(s)
Aged , Female , Humans , Acromegaly , Blood Glucose , Diabetes Mellitus , Diabetes Mellitus, Type 2 , Diagnosis , Duodenum , Endocrine System Diseases , Endoscopy, Digestive System , Follow-Up Studies , Foot , Gastrinoma , Gastrins , Glucose , Growth Hormone , Hand , Hemorrhage , Hyperglycemia , Hyperparathyroidism, Primary , Hypertrophy , Insulin , Insulin-Like Growth Factor I , Multiple Endocrine Neoplasia Type 1 , Multiple Endocrine Neoplasia , Myocardial Ischemia , Neuroendocrine Tumors , Pancreatitis , Polydipsia , Polyuria , Somatostatin , Stomach , Stroke , Weight Loss
13.
Journal of the Korean Medical Association ; : 800-805, 2017.
Article in Korean | WPRIM | ID: wpr-170888

ABSTRACT

There are two types of refractory nocturnal enuresis. The first type corresponds to patients who are refractory from initial success, and the second type refers to refractory nocturnal enuresis after long-term success, in patients who cannot discontinue medications for enuresis. In the former type, it is necessary to determine whether the timing of medications is appropriate, whether the usage of antidiuretics is appropriate, whether any lifestyle changes have taken place, and whether there are secondary causes of enuresis. In the latter type, enuretic alarm treatment should be considered initially, and it is then important to investigate whether a respiratory obstruction is present in patients with nocturnal polyuria, whether the patient is constipated, and whether patients with non-monosymptomatic nocturnal enuresis have lower urinary tract symptoms or attention deficit hyperactivity disorder.


Subject(s)
Humans , Attention Deficit Disorder with Hyperactivity , Drug Resistance , Drug Therapy , Enuresis , Life Style , Lower Urinary Tract Symptoms , Nocturnal Enuresis , Polyuria
14.
Korean Journal of Medicine ; : 186-189, 2017.
Article in Korean | WPRIM | ID: wpr-193483

ABSTRACT

A 32-year-old pregnant woman (34 + 5 weeks) was admitted with dizziness, nausea, and vomiting. Previously, she was diagnosed with gestational diabetes mellitus at 28 weeks with 100 g-OGTT and insulin therapy was started. Her average fasting glucose level was 97 mg/dL and postprandial 1-hour glucose level was 130 mg/dL with basal-bolus insulin therapy (total dose of 28-30 IU/day). At 34 + 0 weeks of gestational age, polyuria and unexpected weight loss (2 kg/week) with hyperglycemia occurred, and total dose of daily insulin requirement was increased up to 50 IU/day. At admission, her serum glucose level was high (502 mg/dL), and urinalysis revealed ketonuria +3. Arterial blood gas analysis revealed pH of 6.83, pCO2 of 9 mmHg, and bicarbonate of 2 mmol/L with an anion gap of 23.5 mmol/L. The diagnosis of diabetic ketoacidosis was established and emergency caesarean section was conducted due to fetal distress. She was finally diagnosed with fulminant type 1 diabetes mellitus, and multiple daily insulin injection therapy was continued after delivery.


Subject(s)
Adult , Female , Humans , Pregnancy , Acid-Base Equilibrium , Blood Gas Analysis , Blood Glucose , Cesarean Section , Diabetes Mellitus, Type 1 , Diabetes, Gestational , Diabetic Ketoacidosis , Diagnosis , Dizziness , Emergencies , Fasting , Fetal Distress , Gestational Age , Glucose , Hydrogen-Ion Concentration , Hyperglycemia , Insulin , Ketosis , Nausea , Polyuria , Pregnant Women , Urinalysis , Vomiting , Weight Loss
15.
Electrolytes & Blood Pressure ; : 23-25, 2017.
Article in English | WPRIM | ID: wpr-29647

ABSTRACT

A 17-year-old girl presented with polyuria (7 L/day) and polydipsia for one year. Initial urine osmolality was 113mOsm/kg H₂O. Following 6 h of fluid restriction, serum plasma osmolality reached 300mOsm/kg H₂O, whereas urine osmolality was 108mOsm/kg H₂O. Urine osmolality was increased by 427% from 108 to 557mOsm/kg after vasopressin challenge. The patient was diagnosed with central diabetes insipidus, possibly derived from the atypical occupation of a Rathke's cleft cyst at the pituitary stalk following magnetic resonance imaging with enhancement. She was discharged with desmopressin nasal spray (10 µg); urine output was maintained at 2-3 L/day, and urine osmolality was >300 mOsm/kg. Additional pituitary image studies and evaluation of hypopituitarism should be included in the differential diagnosis of patients with central diabetes insipidus.


Subject(s)
Adolescent , Female , Humans , Deamino Arginine Vasopressin , Diabetes Insipidus, Neurogenic , Diagnosis, Differential , Hypopituitarism , Magnetic Resonance Imaging , Occupations , Osmolar Concentration , Pituitary Gland , Plasma , Polydipsia , Polyuria , Vasopressins
16.
Chonnam Medical Journal ; : 64-69, 2016.
Article in English | WPRIM | ID: wpr-788324

ABSTRACT

We examined the clinical and laboratory characteristics of children newly diagnosed with diabetes mellitus (DM) in a single-center study. We retrospectively reviewed the data of 155 children with DM between January 2000 and December 2013. Of 155 diabetic children, 87 (56.1%) were diagnosed with type 1 DM (T1DM) and 68 (43.9%) with type 2 DM (T2DM). Mean ages at diagnosis were 8.95+/-3.89 years (T1DM) and 13.76+/-2.23 years (T2DM), respectively (p<0.001). There were significant differences in HbA1c, C-peptide, and glutamic acid decarboxylase antibody levels between the T1DM and T2DM groups. Annual numbers of children with DM have increased, and since 2011 the number of children with T2DM has surpassed the number with T1DM. The most common clinical symptom in T1DM was polyuria, and 26.4% of children with T1DM presented initially with diabetic ketoacidosis. In contrast, 60.3% of T2DM children showed glucosuria in a school urine screening, and only 19.1% presented with polydipsia. The rate of positivity for at least more than one islet autoantibody was 77.1% in T1DM and 26.3% in T2DM. Serum C-peptide levels in T2DM were increased up to 12 months after onset and remained >3.59 ng/mL for 36 months. However, serum C-peptide levels in T1DM were slightly increased up to 6 months after onset and gradually decreased to 0.32 ng/mL for 36 months. The prevalence of children with DM has increased over the last 14 years, and the proportion of T2DM patients has rapidly increased since 2009. Because childhood DM is associated with several metabolic and cardiovascular complications, children should be screened for early detection of DM, especially asymptomatic T2DM in children and adolescents.


Subject(s)
Adolescent , Child , Humans , C-Peptide , Diabetes Mellitus , Diabetic Ketoacidosis , Diagnosis , Glutamate Decarboxylase , Mass Screening , Polydipsia , Polyuria , Prevalence , Retrospective Studies
17.
Childhood Kidney Diseases ; : 88-91, 2016.
Article in English | WPRIM | ID: wpr-218761

ABSTRACT

Nephrogenic diabetes insipidus (NDI) can cause nonobstructive hydronephrosis. Congenital NDI (CNDI) is caused by a genetic mutation. This case report presents a 12-year-old girl who was incidentally diagnosed with nonobstructive hydronephrosis due to NDI caused by AQP2 gene mutation after being evaluated for microscopic hematuria found on routine health examination at school. The patient's medical and family history was unremarkable, and she complained of nocturia only at the time of the clinic visit. Bilateral hydronephrosis on abdominal ultrasonography prompted a water deprivation test, leading to diagnosis of NDI. Genetic study confirmed p.Asn (AAC)123Ser (AGC) in exon 2 of the AQP2 gene. Polyuria and hydronephrosis improved following arginine-vasopressin therapy. CNDI responsive to treatment should be considered as a possible cause of nonobstructive hydroureter.


Subject(s)
Child , Female , Humans , Ambulatory Care , Diabetes Insipidus, Nephrogenic , Diagnosis , Exons , Hematuria , Hydronephrosis , Nocturia , Polyuria , Ultrasonography , Water Deprivation
18.
Annals of Pediatric Endocrinology & Metabolism ; : 51-55, 2016.
Article in English | WPRIM | ID: wpr-34964

ABSTRACT

In males, precocious puberty (PP) is defined as the development of secondary sexual characteristics before age 9 years. PP is usually idiopathic; though, organic abnormalities including tumors are more frequently found in male patients with PP. However, advanced puberty in male also can be an important clinical manifestation in tumors. We report 2 cases of rapidly progressive puberty in males, each associated with a germ-cell tumor. First, an 11-year-old boy presented with mild fever and weight loss for 1 month. Physical examination revealed a pubertal stage of G3P3 with 10-mL testes. Investigations revealed advanced bone age (16 years) with elevated basal luteinizing hormone and testosterone levels. An anterior mediastinal tumor was identified by chest radiography and computed tomography, and elevated α-fetoprotein (AFP) and β-human chorionic gonadotropin (β-hCG) levels were noted. Histopathologic analysis confirmed a yolk-sac tumor. Second, a 12-year-old boy presented with diplopia, polydipsia, and polyuria for 4 months. Physical examination revealed a pubertal stage of G3P3 with 8-mL testes. Bone age was advanced (16 years) and laboratory tests indicated panhypopituitarism with elevated testosterone level. A mixed germ-cell tumor was diagnosed with elevated AFP and β-hCG levels. Of course, these patients also have other symptoms of suspecting tumors, however, rapidly progressive puberty can be the more earlier screening sign of tumors. Therefore, in male patients with accelerated or advanced puberty, malignancy should be considered, with evaluation of tumor markers. In addition, advanced puberty in male should be recognized more widely as a unique sign of neoplasm.


Subject(s)
Adolescent , Child , Humans , Male , Chorionic Gonadotropin , Diplopia , Fever , Luteinizing Hormone , Mass Screening , Physical Examination , Polydipsia , Polyuria , Puberty , Puberty, Precocious , Radiography , Testis , Testosterone , Thorax , Biomarkers, Tumor , Weight Loss
19.
International Neurourology Journal ; : 304-310, 2016.
Article in English | WPRIM | ID: wpr-44722

ABSTRACT

PURPOSE: The aims of this study were to assess the prevalence of nocturia and nocturnal polyuria (NP) and to define new cutoff values according to age and sex for both conditions. METHODS: Data from a population-based prevalence survey conducted among a random sample of 2,128 adults were analyzed in this study. Participants were requested to fill out a questionnaire including the International Continence Society (ICS) definitions of lower urinary tract symptoms and the International Consultation on Incontinence Questionnaire - Short Form. Additionally, a 1-day bladder diary was given to each individual. The participants were divided into 5 age groups. The prevalence of nocturia was calculated based on definitions of nocturia as ≥1 voiding episodes, ≥2 episodes, and ≥3 episodes. NP was evaluated according to the ICS definition. The mean±standard errors and 95th percentile values were calculated in each group as new cutoff values for NP. RESULTS: The prevalence of nocturia was estimated as 28.4%, 17.6%, and 8.9% for ≥1, ≥2, and ≥3 voiding episodes each night, respectively. When nocturia was defined as 2 or more voiding episodes at night, the prevalence decreased significantly. The mean NP index was 29.4%±15.0% in men and 23.1%±11.8% in women. For the age groups of <50 years, 50–59 years, and ≥60 years, the new cutoff values for the diagnosis of NP were calculated as 48%, 69%, and 59% for men and 41%, 50%, and 42% for women, respectively. CONCLUSIONS: We found that the definition of nocturia was still controversial and that waking up once for voiding might be within the normal spectrum of behavior. The definition of NP should be modified, and new cutoff values should be defined using the data presented in our study and in other forthcoming studies.


Subject(s)
Adult , Female , Humans , Male , Diagnosis , Lower Urinary Tract Symptoms , Nocturia , Polyuria , Prevalence , Urinary Bladder
20.
Korean Journal of Pediatrics ; : 202-204, 2016.
Article in English | WPRIM | ID: wpr-57441

ABSTRACT

A 15-year-old boy, who was diagnosed with Alport syndrome and end-stage renal disease, received a renal transplant from a living-related donor. On postoperative day 1, his daily urine output was 10,000 mL despite normal graft function. His laboratory findings including urine, serum osmolality, and antidiuretic hormone levels showed signs similar to central diabetes insipidus, so he was administered desmopressin acetate nasal spray. After administering the desmopressin, urine specific gravity and osmolality increased abruptly, and daily urine output declined to the normal range. The desmopressin acetate was tapered gradually and discontinued 3 months later. Graft function was good, and urine output was maintained within the normal range without desmopressin 20 months after the transplantation. We present a case of a massive polyuria due to transient deficiency of antidiuretic hormone with the necessity of desmopressin therapy immediately after kidney transplantation in a pediatric patient.


Subject(s)
Adolescent , Humans , Male , Deamino Arginine Vasopressin , Diabetes Insipidus, Neurogenic , Kidney Failure, Chronic , Kidney Transplantation , Kidney , Nephritis, Hereditary , Osmolar Concentration , Polyuria , Reference Values , Specific Gravity , Tissue Donors , Transplants
SELECTION OF CITATIONS
SEARCH DETAIL